Schedule

All agenda sessions are in Eastern Time.

Print Schedule
Day 1

Friday, March 20, 2026

Registration

7:30-8:00 am

Welcome Remarks

Carl Salzman; Matcheri Keshavan

8:00-8:15 am

Update on the Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance

Matcheri Keshavan

8:15-9:00 am

Developing New Treatments for Major Depression: One Step Forward and Two Steps Back?

Alan Schatzberg

9:00-9:45 am

Treatment of Bipolar Disorders; Neurobiology and Clinical Directions; Revival of Lithium

Roscoe Brady

9:45-10:30 am

Coffree Break

10:30-10:45 am

Update: The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause

Kristina Deligiannidis

10:45-11:30 am

Psychopharmacologic Approaches in Childhood affective disorders

Melissa DelBello

11:30 am-12:15 pm

Panel Discussion # 1

Matcheri Keshavan; Alan Schatzberg; Kristina Deligiannidis; Melissa DelBello; Roscoe Brady

12:15-12:45 pm

Lunch

12:45-1:45 pm

Clinical Relevance of Brain Circuity for Psychiatric Treatment

Roscoe Brady

1:45-2:30 pm

Psychopharmacology in geriatrics and neuropsychiatry

Alejandro Dan Mendoza

2:30-3:15 pm

Coffee Break

3:15-3:30 pm

Therapeutic Approaches to the Difficult Patient

Stephen Stahl

3:30-4:15 pm

Panel Discussion # 2

Stephen Stahl; Roscoe Brady; Alejandro Dan Mendoza

4:15-5:00 pm

Day 2

Saturday, March 21, 2026

Treatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities

Matcheri Keshavan

8:30-9:15 am

Neurobiology and treatment of Sleep in Psychiatric Disorders

John Winkelman; Tony Cunningham

9:15-10:15 am

Coffee Break

10:15-10:30 am

Update: Digital Phenotyping in Psychiatry and Psychopharmacology; Role of AI?

John Torous

10:30-11:15 am

Mechanisms of Psychedelics and Their Potential Treatment for PTSD

Ryan Henner

11:15 am-12:00 pm

Panel Discussion

Carl Salzman; John Torous; John Winkelman; Ryan Henner; Tony Cunningham

12:00-12:45 pm

Lunch

12:45-1:45 pm

Update: Effective Treatment of Substance Use Disorders

Kevin Hill; Pooja Sarkar

1:45-2:30 pm

Treatment of Anxiety Spectrum Disorders, and PTSD, New Benzodiazepine Data

Carl Salzman

2:30-3:15 pm

Coffee Break

3:15-3:30 pm

Psychopharmacology of trauma related disorders

Charles Nemeroff

3:30-4:15 pm

Panel Discussion

Carl Salzman; Kevin Hill; Charles Nemeroff; Matcheri Keshavan

4:15-4:45 pm

Wrap-Up, Last Questions

4:45-5:00 pm